Graft vs host disease
Showing 1 - 25 of >10,000
Graft Vs Host Disease, Graft-versus-host-disease, GVHD Trial in Saint Louis (Ruxolitinib)
Not yet recruiting
- Graft Vs Host Disease
- +2 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 18, 2023
Steroid Refractory GVHD Trial in Taoyuan (Ruxolitinib)
Completed
- Steroid Refractory GVHD
-
Taoyuan, TaiwanChang Gung Memorial Hospital
Dec 15, 2022
Tacrolimus Blood Concentration and Transplant-related Outcomes
Recruiting
- Graft Vs Host Disease
- +2 more
- TAC C/D ratio
-
Trieste, ItalyIRCCS Burlo Garofolo
Oct 6, 2023
Evaluation of the Impact of Reduced Immunosuppression
Enrolling by invitation
- Graft Vs Host Disease
-
Dallas, TexasMethodist Dallas Medical Center
Dec 20, 2022
Alterations in Intestinal Microbiota, Metabolites, and Immune
Recruiting
- Graft Vs Host Disease
- Blood Sample
- +2 more
-
Suzhou, Jiangsu, ChinaThe First Affiliated Hospital of Soochow University
Nov 16, 2023
Patients at Risk for Chronic Graft-Versus-Host Disease
Not yet recruiting
- cGVHD
- Non-Interventional
- (no location specified)
Jun 16, 2023
Myelodysplastic/Myeloproliferative Tumor, Steroid Refractory GVHD, Allogeneic Hematopoietic Cell Transplant Trial in Toronto
Completed
- Myelodysplastic/Myeloproliferative Neoplasm
- +2 more
- Decidual stromal cells (DSC)
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Jan 8, 2023
Graft Vs Host Disease, Acute-graft-versus-host Disease, Chronic Graft-versus-host-disease Trial in Boston (Exercise, Attention
Recruiting
- Graft Vs Host Disease
- +2 more
- Exercise
- Attention control
-
Boston, Massachusetts
- +1 more
Nov 28, 2022
Acute GVHD Trial (Itolizumab, Methylprednisolone)
Not yet recruiting
- Acute Graft Versus Host Disease
- (no location specified)
Apr 10, 2023
Mesenchymal Stem Cells Trial in Shapingba (Mesenchymal Stem Cells (MSCs))
Recruiting
- Mesenchymal Stem Cells
- Mesenchymal Stem Cells (MSCs)
-
Shapingba, Chongqing, ChinaXinqiao Hospital
Nov 24, 2023
Chronic GVHD, Chronic GVHD Trial run by the NCI (Baricitinib)
Active, not recruiting
- Chronic Graft vs Host Disease
- Chronic Graft-Versus-Host Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Nov 29, 2022
A PMS of Jakavi® in Steroid-Refractory Graft-versus-Host Disease
Not yet recruiting
- Graft-versus-Host Disease
- ruxolitinib
- (no location specified)
Jan 11, 2023
Steroid-refractory Acute Graft-versus-host Disease Trial (MC0518, BAT)
Not yet recruiting
- Steroid-refractory Acute Graft-versus-host Disease
- MC0518
- BAT
- (no location specified)
Oct 4, 2023
Graft Vs Host Disease, Graft-versus-host-disease, Acute Myeloid Leukemia Trial (CliniMACS® device)
Not yet recruiting
- Graft Vs Host Disease
- +5 more
- CliniMACS® device
- (no location specified)
Jul 20, 2023
Acute GVHD, Hematopoietic and Lymphoid System Tumor Trial in Seattle (Fecal Microbiota Transplantation Capsule, Placebo)
Not yet recruiting
- Acute Graft Versus Host Disease
- Hematopoietic and Lymphoid System Neoplasm
- Fecal Microbiota Transplantation Capsule
- Placebo
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 6, 2023
Photopheresis in GvHD After Hematopoietic Transplantation:
Enrolling by invitation
- Graft Vs Host Disease
- Extracorporeal Photopheresis
- Extracorporeal Photopheresis
-
Roma, ItalyFondazione Policlinico Universitario Agostino Gemelli (FPG) - IR
Feb 7, 2023
Graft Vs Host Disease Trial in Puebla (Cyclophosphamide)
Enrolling by invitation
- Graft Vs Host Disease
-
Puebla, MexicoCentro de Hematología y Medicina Interna
Mar 22, 2023
Acute GVHD Trial (MTX, Corticosteroid)
Not yet recruiting
- Acute Graft Versus Host Disease
- (no location specified)
Jun 26, 2023
GVHD, Postbiotics, Butyrate Trial in Seoul (sodium butyrate)
Recruiting
- Graft Versus Host Disease
- +2 more
- sodium butyrate
-
Seoul, Korea, Republic ofSoonchunhyang University Seoul Hospital
Apr 11, 2023
Clinical and Biological Factors Determining Outcomes in Chronic
Recruiting
- Chronic Graft vs Host Disease
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Chronic GVHD, Allogeneic Stem Cell Transplant Trial in Boston (App, Usual Care)
Recruiting
- Chronic Graft-Versus-Host Disease
- Allogeneic Stem Cell Transplant
- App
- Usual Care
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 24, 2023
Acute Graft Versus Host Disease
Not yet recruiting
- GVHD,Acute
- blood sample
-
Detroit, MichiganHenry Ford Health System
Jan 30, 2023